MARKET

ODT

ODT

Odonate Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.320
+0.060
+1.84%
Opening 10:26 04/21 EDT
OPEN
3.200
PREV CLOSE
3.260
HIGH
3.320
LOW
3.180
VOLUME
161.62K
TURNOVER
--
52 WEEK HIGH
46.50
52 WEEK LOW
3.020
MARKET CAP
128.16M
P/E (TTM)
-0.8582
1D
5D
1M
3M
1Y
5Y
OGI, TLRY, APHA among premarket losers
Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -...
Seekingalpha · 04/13 12:31
Odonate Therapeutics (ODT) is Oversold: Can It Recover?
Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Zacks · 04/09 12:17
Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers
Gainers: Auris Medical (EARS) +18%, Prometheus Biosciences (RXDX) +15%, Crinetics Pharmaceuticals (CRNX) +13%, Genprex (GNPX) +12%, Fortress Biotech (FBIO) +12%.Losers: Endo International (ENDP) -10%, Odonate Therapeutics (ODT) -9%, Otonomy (OTIC) -8%, Bro...
Seekingalpha · 04/08 15:05
Is Odonate Therapeutics (NASDAQ:ODT) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Simply Wall St. · 04/08 11:26
GEO, OCGN, SOS and CXW among midday movers
Gainers: Bonso Electronics International (BNSO) +36%.SOS (SOS) +29%.Ouster (OUST) +29%.ION Geophysical (IO) +22%.Odonate Therapeutics (ODT) +20%.Titan Medical (TMDI) +16%.Cocrystal Pharma (COCP) +15%.Ocugen (OCGN) +15%.Pintec Technology (PT) +13%.Frequency...
Seekingalpha · 04/07 16:44
Odonate Therapeutics, Ocugen leads healthcare gainers; FibroGen, Homology Medicines among major losers
Gainers: Odonate Therapeutics (ODT) +34%, Ocugen (OCGN) +24%, Titan Medical (TMDI) +15%, Frequency Therapeutics (FREQ) +14, 9 Meters Biopharma (NMTR) +10%%.Losers: FibroGen (FGEN) -39%, Homology Medicines (FIXX) -18%, Galectin Therapeutics (GALT) -14%, Bro...
Seekingalpha · 04/07 15:01
AKBA, SYBX, FGEN and FIXX among after-hours movers
Gainers: [[AKBA]] +12.1%. [[SYBX]] +7.1%. [[ARDX]] +5.2%. [[ODT]] +4.9%. [[BYND]] +4.2%.Losers: [[FGEN]] -29.2%. [[FIXX]] -10.2%. [[MAXN]] -6.8%. [[IONS]] -5.8%. [[OM]] -5.4%.
Seekingalpha · 04/06 21:39
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The earnings news flow was confined to micro- and small-cap companies. Five biopharma companies listed their shares on the Nasd...
Benzinga · 03/27 14:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ODT. Analyze the recent business situations of Odonate Therapeutics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ODT stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 137
Institutional Holdings: 38.69M
% Owned: 100.22%
Shares Outstanding: 38.60M
TypeInstitutionsShares
Increased
39
3.25M
New
21
237.31K
Decreased
23
1.53M
Sold Out
16
589.42K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.78%
Pharmaceuticals & Medical Research
+0.71%
Key Executives
Chairman/Chief Executive Officer/Director
Kevin Tang
Chairman/Chief Executive Officer/Director
kevin Tang
Chief Financial Officer
Michael Hearne
Other
Joseph O'Connell
Director
Robert Rosen
Independent Director
Aaron Davis
Independent Director
Laura Douglass
Independent Director
Craig Johnson
No Data
About ODT
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

Webull offers kinds of Odonate Therapeutics Inc stock information, including NASDAQ:ODT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ODT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ODT stock methods without spending real money on the virtual paper trading platform.